IIT Research Institute (IITRI) is a leading preclinical contract research organization that offers a wide range of services. They specialize in GLP-compliant IND-enabling toxicology studies, inhalation toxicology programs, and vaccine and infectious disease therapeutic development. With their onsite bioanalytical facilities, IITRI provides comprehensive preclinical development services, including genetic toxicology studies, reproductive toxicology, carcinogenicity studies, and NDA-enabling studies.

They also offer gene therapy preclinical studies, immuno-oncology services, and marmoset studies for preclinical toxicology. In the field of inhalation toxicology, IITRI is a trusted provider of in vivo GLP inhalation toxicology studies for e-cigarettes, ENDS, and tobacco products. They also specialize in exposure atmosphere characterization and infusion toxicology studies.

Additionally, IITRI is actively involved in biodefense and infectious disease research, including COVID-19 studies. Their expertise spans a range of animal models and in vitro assays for infectious diseases such as Zika, Influenza, F. IITRI's services extend to drug discovery, immunology, vaccine and antiviral development, as well as bioanalytical method development and validation.

With a strong commitment to quality control, quality assurance, and animal welfare, IITRI is a trusted partner in the field of preclinical research. Contact them today to learn more about their services and discuss your research needs